Dyslipidemia and Treatments

Loading the player...

ODYSSEY Gregory Schwartz, MD, PhD

Gregory Schwartz, MD, Phd, Co-Chair of the Executive Steering Committee for ODYSSEY summarizes the results of the trial.

Science NewsView All Science News

...
CIRCULATION Editor's Picks May 2018
05/16/2018 | CIRCULATON Editor's Picks for May 2018
...
CIRCULATION Feature Articles May 8, 2018: REAL-CAD
05/08/2018 | High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): Randomized Superiority Trial
...
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated with Intracranial Aneurysm Rupture
04/05/2018
...
Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014)
03/26/2018

EPI | LIFESTYLE 2018 Scientific Sessions

Epidemiology and Prevention | Lifestyle and Cardiometabolic Health 2018 Scientific Sessions
March 20–23, 2018
Sheraton New Orleans
New Orleans, Louisiana
 

Learn About EPI | Lifestyle 2018

Networking for Professionals

Scientific Sessions OnDemand: A Professional Heart Daily Resource | Experience Scientific Sessions 2017 anytime, anywhere! Order individual sessions, or buy the full program & receive a $500 Amazon gi
Scientific Sessions 2018

Nov. 10–12, 2018
Chicago, Illinois

The Data and Resources You Need---All in One Place. Harness the power of an open science community to accelerate your work. -- Get Started
For HF patients, the path to a better quality of life begins here. HF Path(tm) Learn More
AHA/ASA Professional Membership

AHA / ASA Professional Members are Difference Makers.

Join Today
 
Image for Monthly Messaging Widget

About 1 in 4 stroke survivors suffers another one. Work with your patients to reduce their risk.

Get American Stroke Month Healthcare Professionals Resources

Join the conversation on Twitter at #StrokeMonth.

Related Councils

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Steven R. Lentz, MD, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

ATVB|PVD Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Lifestyle and Cardiometabolic Health

Jean-Pierre Després, PhD, FAHA, FIAS

The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. Our council promotes basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavior change.

Jean-Pierre Després, PhD, FAHA, FIAS
Chair, Council on Lifestyle and Cardiometabolic Health

EPI|Lifestyle Scientific Sessions       Circulation       Lifestyle Council Awards

Council on Clinical Cardiology (CLCD)

Randal J. Thomas, MD MS FAHA FACC MAACVPR

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Randal J. Thomas, MD, MS, FAHA, FACC, MAACVPR
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards